Varicella-zoster reactivation in a patient receiving routine revaccinations after an allogeneic hemopoietic progenitors transplant

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 2, 2005, Pages 106-108

  Patel, Soonie R ^a   Ortín, Miguel ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Allogeneic hemopoietic progenitors transplant; Childhood vaccinations; Varicella zoster virus reactivation

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HERPES ZOSTER; HUMAN; IMMUNOMODULATION; INFECTION; LEUKOCYTE COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVACCINATION; TREATMENT OUTCOME; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; VACCINATION;

EID: 13944269585     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000153442.42030.74     Document Type: Article

References (13)

1. Moffat JF, Stein MD, Kaneshima H, et al. Tropism of varicella-zoster virus for human CD4+ and CD8+ lymphocytes and epidermal cells in SCID-hu mice. J Virol. 1995;69:5236-5242.
2. Locksley RM, Flournoy K, Sullivan M, et al. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis. 1985;152:1172-1181.
3. Hakim FT, Gress MD. Reconstitution of thymic function after stem cell transplantation in humans. Curr Opin Hematol. 2002;9:490-496.
4. Arvin AM. Varicella-zoster virus: pathogenesis, immunity and clinical management in haematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2000;6:219-230.
5. Koc Y, Miller KB, Schenkein DP, et al. Varicella-zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors and clinical outcome. Biol Blood Marrow Transplant. 2000;6:44-49.
6. Balfour HH Jr. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Scand J Infect Dis Suppl. 1992;80:69-74.
7. Gilden DH, Dueland AN, Derlin ME, et al. Varicella zoster virus reactivation without rash. J Infect Dis. 1992;166(Supp 1):S30-S34.
8. Sadzot-Delvaux C, Kinchington PR, Dedrus S, et al. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol. 1997;159:2802-2806.
9. Arvin AM, Sharp M, Smith S, et al. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) by cytotoxic T-lymphocytes of either CD4+ or CD8+ phenotype. J Immunol. 1991;146:257-264.
10. Wilson A, Sharp M, Koropchak CM. Subclinical VZV viremia, herpes zoster and T-lymphocyte immunity to varicella zoster virus antigens after bone marrow transplant. J Infect Dis. 1992;165:119-126.
11. Meyers JD, Flournoy N, Thomas ED. Cell-mediated immunity to varicella-zoster virus after allergenic marrow transplant. J Infect Dis. 1980;141:479-487.
12. Lewin SR, Heller G, Zhang L, et al. Direct evidence for new T-cell generation by patients of either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplants. Blood. 2002;100:2235-2242.
13. Walter R, Hartmann K, Pool V, et al. Reactivation of herpes virus infections by vaccination: evidence or coincidence? Schweiz Med Wochenschr. 2000;130:1685-1688.